REGENXBIO, Inc. (RGNX)
6.69
+0.38
(+6.02%)
USD |
NASDAQ |
May 27, 16:00
6.69
0.00 (0.00%)
After-Hours: 16:33
REGENXBIO Free Cash Flow : -236.40M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AbbVie, Inc. | 19.98B |
| Ocugen, Inc. | -59.58M |
| Replimune Group, Inc. | -283.27M |
| Sarepta Therapeutics, Inc. | 91.18M |
| Krystal Biotech, Inc. | 237.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -76.19M |
| Cash from Investing (Quarterly) | 70.59M |
| Cash from Financing (Quarterly) | -13.64M |
| Free Cash Flow Per Share (Quarterly) | -1.477 |
| Free Cash Flow to Equity (Quarterly) | -65.30M |
| Free Cash Flow to Firm (Quarterly) | -68.71M |
| Free Cash Flow Yield | -68.17% |